Recombinant human C1 esterase inhibitor as short-term
prophylaxis in patients with hereditary angioedema

J 2020

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

VALERIEVA, Anna; Maria STAEVSKA; Milos JESENAK; Katarina HRUBISKOVA; Marta SOBOTKOVA et al.

Základní údaje

Originální název

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Autoři

Vydání

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, AMSTERDAM, ELSEVIER, 2020, 2213-2198

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 8.861

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00115435

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY

Štítky

14110114, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 12. 5. 2021 12:56, Mgr. Tereza Miškechová

Anotace

V originále

Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.

Citovat

VALERIEVA, Anna; Maria STAEVSKA; Milos JESENAK; Katarina HRUBISKOVA; Marta SOBOTKOVA; Radana ZACHOVA; Roman HAKL; Sladjana ANDREJEVIC; Tobias SUITER; Vesna GRIVCHEVA-PANOVSKA; Ljerka KARADZA-LAPIC; Daniel SOTERES; Ralph SHAPIRO; Jeffrey RUMBYRT; Raffi TACHDJIAN; Vinay MEHTA; F. Ida HSU a Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2020, roč. 8, č. 2, s. 799-802. ISSN 2213-2198. Dostupné z: https://doi.org/10.1016/j.jaip.2019.08.011.

@article{1637706,
   author = {Valerieva, Anna and Staevska, Maria and Jesenak, Milos and Hrubiskova, Katarina and Sobotkova, Marta and Zachova, Radana and Hakl, Roman and Andrejevic, Sladjana and Suiter, Tobias and GrivchevaandPanovska, Vesna and KaradzaandLapic, Ljerka and Soteres, Daniel and Shapiro, Ralph and Rumbyrt, Jeffrey and Tachdjian, Raffi and Mehta, Vinay and Hsu, F. Ida and Zanichelli, Andrea},
   article_location = {AMSTERDAM},
   article_number = {2},
   doi = {https://doi.org/10.1016/j.jaip.2019.08.011},
   keywords = {C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY},
   language = {eng},
   issn = {2213-2198},
   journal = {JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE},
   title = {Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema},
   url = {http://dx.doi.org/10.1016/j.jaip.2019.08.011},
   volume = {8},
   year = {2020}
}

TY  - JOUR
ID  - 1637706
AU  - Valerieva, Anna - Staevska, Maria - Jesenak, Milos - Hrubiskova, Katarina - Sobotkova, Marta - Zachova, Radana - Hakl, Roman - Andrejevic, Sladjana - Suiter, Tobias - Grivcheva-Panovska, Vesna - Karadza-Lapic, Ljerka - Soteres, Daniel - Shapiro, Ralph - Rumbyrt, Jeffrey - Tachdjian, Raffi - Mehta, Vinay - Hsu, F. Ida - Zanichelli, Andrea
PY  - 2020
TI  - Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
JF  - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
VL  - 8
IS  - 2
SP  - 799-802
EP  - 799-802
PB  - ELSEVIER
SN  - 22132198
KW  - C1-INHIBITOR
KW  - ATTACKS
KW  - DEFICIENCY
KW  - EFFICACY
UR  - http://dx.doi.org/10.1016/j.jaip.2019.08.011
L2  - http://dx.doi.org/10.1016/j.jaip.2019.08.011
N2  - Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.
ER  -

VALERIEVA, Anna; Maria STAEVSKA; Milos JESENAK; Katarina HRUBISKOVA; Marta SOBOTKOVA; Radana ZACHOVA; Roman HAKL; Sladjana ANDREJEVIC; Tobias SUITER; Vesna GRIVCHEVA-PANOVSKA; Ljerka KARADZA-LAPIC; Daniel SOTERES; Ralph SHAPIRO; Jeffrey RUMBYRT; Raffi TACHDJIAN; Vinay MEHTA; F. Ida HSU a Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. \textit{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}. AMSTERDAM: ELSEVIER, 2020, roč.~8, č.~2, s.~799-802. ISSN~2213-2198. Dostupné z: https://doi.org/10.1016/j.jaip.2019.08.011.

Přehled o publikaci